These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29648813)

  • 1. Small Molecule Neuropilin-1 Antagonists Combine Antiangiogenic and Antitumor Activity with Immune Modulation through Reduction of Transforming Growth Factor Beta (TGFβ) Production in Regulatory T-Cells.
    Powell J; Mota F; Steadman D; Soudy C; Miyauchi JT; Crosby S; Jarvis A; Reisinger T; Winfield N; Evans G; Finniear A; Yelland T; Chou YT; Chan AWE; O'Leary A; Cheng L; Liu D; Fotinou C; Milagre C; Martin JF; Jia H; Frankel P; Djordjevic S; Tsirka SE; Zachary IC; Selwood DL
    J Med Chem; 2018 May; 61(9):4135-4154. PubMed ID: 29648813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Neuropilin-1 Antagonist Exerts Antitumor Immunity by Inhibiting the Suppressive Function of Intratumoral Regulatory T Cells.
    Jung K; Kim JA; Kim YJ; Lee HW; Kim CH; Haam S; Kim YS
    Cancer Immunol Res; 2020 Jan; 8(1):46-56. PubMed ID: 31554638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel nonpeptide small-molecule NRP1 antagonists: Virtual screening, molecular simulation and structural modification.
    Peng K; Li Y; Bai Y; Jiang T; Sun H; Zhu Q; Xu Y
    Bioorg Med Chem; 2020 Jan; 28(1):115183. PubMed ID: 31744780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ablation of Neuropilin 1 from glioma-associated microglia and macrophages slows tumor progression.
    Miyauchi JT; Chen D; Choi M; Nissen JC; Shroyer KR; Djordevic S; Zachary IC; Selwood D; Tsirka SE
    Oncotarget; 2016 Mar; 7(9):9801-14. PubMed ID: 26755653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecule inhibitors of the neuropilin-1 vascular endothelial growth factor A (VEGF-A) interaction.
    Jarvis A; Allerston CK; Jia H; Herzog B; Garza-Garcia A; Winfield N; Ellard K; Aqil R; Lynch R; Chapman C; Hartzoulakis B; Nally J; Stewart M; Cheng L; Menon M; Tickner M; Djordjevic S; Driscoll PC; Zachary I; Selwood DL
    J Med Chem; 2010 Mar; 53(5):2215-26. PubMed ID: 20151671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin Fc-fused, neuropilin-1-specific peptide shows efficient tumor tissue penetration and inhibits tumor growth via anti-angiogenesis.
    Kim YJ; Bae J; Shin TH; Kang SH; Jeong M; Han Y; Park JH; Kim SK; Kim YS
    J Control Release; 2015 Oct; 216():56-68. PubMed ID: 26260451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+Foxp3+T Regulatory Cells Promote Transplantation Tolerance by Modulating Effector CD4+ T Cells in a Neuropilin-1-Dependent Manner.
    Campos-Mora M; Contreras-Kallens P; Gálvez-Jirón F; Rojas M; Rojas C; Refisch A; Cerda O; Pino-Lagos K
    Front Immunol; 2019; 10():882. PubMed ID: 31068948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropilin 1: function and therapeutic potential in cancer.
    Chaudhary B; Khaled YS; Ammori BJ; Elkord E
    Cancer Immunol Immunother; 2014 Feb; 63(2):81-99. PubMed ID: 24263240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropilin-1 expression identifies a subset of regulatory T cells in human lymph nodes that is modulated by preoperative chemoradiation therapy in cervical cancer.
    Battaglia A; Buzzonetti A; Monego G; Peri L; Ferrandina G; Fanfani F; Scambia G; Fattorossi A
    Immunology; 2008 Jan; 123(1):129-38. PubMed ID: 18028372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of neuropilin-1 by RNA-interference and its angiostatic potential in the treatment of hepatocellular carcinoma.
    Raskopf E; Vogt A; Standop J; Sauerbruch T; Schmitz V
    Z Gastroenterol; 2010 Jan; 48(1):21-7. PubMed ID: 20072992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuftsin signals through its receptor neuropilin-1 via the transforming growth factor beta pathway.
    Nissen JC; Selwood DL; Tsirka SE
    J Neurochem; 2013 Nov; 127(3):394-402. PubMed ID: 24033337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
    Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
    J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropilin-1 antagonism in human carcinoma cells inhibits migration and enhances chemosensitivity.
    Jia H; Cheng L; Tickner M; Bagherzadeh A; Selwood D; Zachary I
    Br J Cancer; 2010 Feb; 102(3):541-52. PubMed ID: 20087344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid hormone differentially modulates the in vitro expansion and cytokine profile of thymic and splenic Treg cells.
    Pap R; Ugor E; Litvai T; Prenek L; Najbauer J; Németh P; Berki T
    Immunobiology; 2019 Mar; 224(2):285-295. PubMed ID: 30612787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus.
    Sobel ES; Brusko TM; Butfiloski EJ; Hou W; Li S; Cuda CM; Abid AN; Reeves WH; Morel L
    Arthritis Res Ther; 2011 Jun; 13(3):R106. PubMed ID: 21708033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical Efficacy and Safety of an Anti-Human VEGFA and Anti-Human NRP1 Dual-Targeting Bispecific Antibody (IDB0076).
    Ko JH; Kwon HS; Kim B; Min G; Shin C; Yang SW; Lee SW; Lee Y; Hong D; Kim YS
    Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32560565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropilin-1 is a receptor for transforming growth factor beta-1, activates its latent form, and promotes regulatory T cell activity.
    Glinka Y; Prud'homme GJ
    J Leukoc Biol; 2008 Jul; 84(1):302-10. PubMed ID: 18436584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure-activity relationship of non-peptidic antagonists of neuropilin-1 receptor.
    Liu WQ; Megale V; Borriello L; Leforban B; Montès M; Goldwaser E; Gresh N; Piquemal JP; Hadj-Slimane R; Hermine O; Garbay C; Raynaud F; Lepelletier Y; Demange L
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4254-9. PubMed ID: 25091928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropilin-1 modulates TGFβ signaling to drive glioblastoma growth and recurrence after anti-angiogenic therapy.
    Kwiatkowski SC; Guerrero PA; Hirota S; Chen Z; Morales JE; Aghi M; McCarty JH
    PLoS One; 2017; 12(9):e0185065. PubMed ID: 28938007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-γ Drives T
    Overacre-Delgoffe AE; Chikina M; Dadey RE; Yano H; Brunazzi EA; Shayan G; Horne W; Moskovitz JM; Kolls JK; Sander C; Shuai Y; Normolle DP; Kirkwood JM; Ferris RL; Delgoffe GM; Bruno TC; Workman CJ; Vignali DAA
    Cell; 2017 Jun; 169(6):1130-1141.e11. PubMed ID: 28552348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.